Skip to main content
Fig. 8 | BMC Rheumatology

Fig. 8

From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

Fig. 8

Comparison of anti-Spike IgG levels in CoronaVac and BNT162b2 groups in terms of different drug use (Drug positive or drug negative) (*Study population is evaluated for each drug, according to specific drug use.) (** Median anti-Spike IgG levels were shown.) (MTX: Methotrexate, CS: Corticosteroid, HCQ: Hydroxychloroquine, LEF: Leflunomide, TNFi: Tumor Necrosis Factor inhibitors, SSZ: Sulfasalazine) a Comparison in CoronaVac group b Comparison in BNT162b2 group

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us